Kymera Therapeutics (KYMR) Receivables - Other (2020 - 2025)
Kymera Therapeutics' Receivables - Other came in at $20 million for Q1 2025, up 885.2% from $2.03 million a year earlier.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Receivables - Other (2020 - 2025) Analysis & Trends
At the end of FY2024, Kymera Therapeutics' Receivables - Other was $947,000, down 75.1% from FY2023.
- Receivables - Other carries a four-year compound annual growth rate of 1.3% (FY2020 to FY2024).
- Going back by year, Receivables - Other was $3.8 million in FY2023 (+49.8%), $2.54 million in FY2022, $135,000 in FY2021 (-85.0%) and $900,000 in FY2020.
- The Q1 2025 figure represents the highest quarterly Receivables - Other in data going back to Q3 2020.
- Year-over-year, Receivables - Other increased in four of the last eight quarters, with growth averaging 99.7%.
- The fastest year-over-year change in Receivables - Other over five years came in Q1 2025 (growth of 885.2%), and the weakest in Q4 2021 (a decline of 84.2%).
- Business Quant data shows KYMR's Receivables - Other at $900,000 (Q4 2024), $1.32 million (Q3 2024) and $1.7 million (Q2 2024) in the three quarters before Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Kymera Therapeutics | 9.15 Bn | 6.45 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 20.00 Mn |
| Dec 31, 2024 | 900,000.00 |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 2.03 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Sep 30, 2023 | 3.80 Mn |
| Jun 30, 2023 | 4.12 Mn |
| Mar 31, 2023 | 3.32 Mn |
| Dec 31, 2022 | 2.54 Mn |
| Sep 30, 2022 | 2.90 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 904,000.00 |
| Mar 31, 2021 | 900,000.00 |
| Dec 31, 2020 | 856,000.00 |
| Sep 30, 2020 | 577,000.00 |
API Access
Kymera Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();